Robert Mittendorf

Robert is a General Partner and Head of Healthcare who leads venture and growth investments at B Capital in the sector. Robert and his team have led investments in Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira OR. He currently serves as a Board Director or Board Observer at Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira. Previously, he served as a Board Director or Observer at Impel NeuroPharma, Silk Road Medical, TigerConnect, Avalyn Pharma, Neocis, Telcare, VisitPay, IntersectENT, iRhythm, Omada, TalkSpace, and iCardiac. Prior to his career in venture capital, Robert led Marketing and Business Development at Hansen Medical. He earned an M.D. from Harvard University, an M.B.A. from Harvard Business School, an M.S. in Systems Engineering from the Massachusetts Institute of Technology, and an M.A. in International Relations from Kings College London.